Recent developments in the field of obesity treatment have presented a innovative therapy known as ALLUVI Retatrutide. This medication is a {highlypotent GLP-1 receptor agonist, designed to amplify the effects of natural glucagon-like peptide-1. Retatrutide has shown significant outcomes in clinical trials, demonstrating significant decreases in bo